News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Akhil Santhosh: Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-NSCLC
cancernetwork.com
Dec 29, 2024, 08:47

Akhil Santhosh: Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-NSCLC

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post on X:

“Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA) -l
– 24%mpr, 0%pcr
– Again, a different study showing that neoadj osi alone is not the way to go forward …waiting eagerly for neoadaura.”

Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-mutant non-small cell lung cancer (NORA)

Authors: Jii Bum Lee et al.

Akhil Santhosh: Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-NSCLC

Akhil Santhosh Byoung Chul Cho Byung Jo Park cancer Chang Young Lee Hyo Sup Shim Jii Bum Lee Lung cancer Min Hee Hong OncoDaily Oncology Sharlene Velichko Su-Jin Choi Sumedha Sudhaman Sun Min Lim
Special Coverage
Blog
Jan 31, 2025, 22:43
Yakup Ergün: External-beam radiation versus TACE for HCC
Blog
Jan 31, 2025, 22:43
Mark Lewis: Running, walking, and crawling are all moving forward, just at different speeds
Insight
Jan 31, 2025, 22:43
Issa Mohamad: Survey of Current Practices for Early-Stage Glottic Squamous Cell Carcinoma
Blog
Jan 31, 2025, 22:43
Monika Pansari: Early detection saves lives
Blog
Jan 31, 2025, 22:43
Bhavin Vadodariya: Team work in cancer surgery
Blog
Jan 31, 2025, 22:43
Europe, the time is now: Liver health can’t wait - ELPA
Blog
Jan 31, 2025, 22:43
Wafaa Rashed: Honored to feature Catherine Metayer in this episode of the PAPERI Bright Minds Series
Blog
Jan 31, 2025, 22:43
The first outreach of the year took us to Stem Child Care Academy - Medicaid Cancer Foundation
Blog
Jan 31, 2025, 22:43
Olubukola Ayodele: Thankful to participate in the Cancer Symposium at the University of Leicester
Blog
Jan 31, 2025, 22:42
Transcriptional States and Dynamics of Circulating Tumor-Infiltrating Lymphocytes during Immunotherapy
Insight
Jan 31, 2025, 19:25
Tanja Obradovic: New Phase III trial with an innovative MOA may soon change the standard of care for second-line MSS CRC
Blog
Jan 31, 2025, 18:05
Shining a light on the EU-funded projects - Association of European Cancer Leagues